Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and Cash Equivalents $ 569,366 $ 18,617,955
Marketable Securities 30,480,537 16,718,452
Other Receivables 3,026,137 1,200,009
Prepaid expenses 214,111 294,343
Current assets of discontinued operations 7,700 12,002
Total Current Assets 34,297,851 36,842,761
Non-Current Assets    
Other Assets 1,500,000
Total Non-Current Assets 1,500,000
Total Assets 35,797,851 36,842,761
Current Liabilities    
Trade and Other Payables 2,335,751 2,203,902
Current liabilities of discontinued operations 38,308 59,393
Total Current Liabilities 2,374,059 2,263,295
Total Liabilities 2,374,059 2,263,295
Commitments and Contingencies
SHAREHOLDERS' EQUITY    
Common stock, no par value, 100,000,000 shares authorized 8,326,730 and 8,792,946 issued and outstanding as of March 31, 2021 and December 31, 2020 171,925,670 171,598,681
Accumulated Deficit (138,646,402) (137,163,739)
Total Shareholders' Equity 33,423,792 34,579,466
Total Liabilities and Shareholders Equity 35,797,851 36,842,761
Series A Convertible Preferred Stock [Member]    
SHAREHOLDERS' EQUITY    
Preferred stock, value
Series C Convertible Preferred Stock [Member]    
SHAREHOLDERS' EQUITY    
Preferred stock, value
Series D Convertible Preferred Stock [Member]    
SHAREHOLDERS' EQUITY    
Preferred stock, value 144,524 144,524
Series E Junior Participating Preferred Stock [Member]    
SHAREHOLDERS' EQUITY    
Preferred stock, value